Bioactive by-products
Catalog | Product Name / CAS / Description | Structure |
---|---|---|
BBF-01147 |
1,6-Dihydroxy-2-chlorophenazine (93768-40-2) Inquiry |
|
It is produced by the strain of Streptosporangium sp. 1656. It has weak anti-fungal and anti-yeast activity. |
||
BBF-01202 |
Elaiomycin (23315-05-1) Inquiry |
|
It is produced by the strain of Streptomyces hepaticus. It has the activity of anti-gram-positive bacteria and negative bacteria, especially has strong effect on mycobacterium tuberculosis. It is a carcinogen. |
||
BBF-01245 | ||
It is produced by the strain of Streptomyces sp. C39. It is a bioactive substance. Gibberellin C of 200 ppm has no inhibitory effect on α-amylase. It also has no anti-bacterial, anti-yeast and anti-fungal effects at 100 ppm (MIC, agar dilution method using bouillon agar for bacteria and Sabouraud agar for yeast and fungi). |
||
BBF-01258 | ||
It is produced by the strain of Streptomyces lavendulae H698 SY2. It has antibacterial activity on several plant pathogenic fungi, including Glomerella cingulata, Colletotrichum gloeosporioides and C. lagenarium with MIC (μg/mL) of 0.78, 0.78 and 1.56, respectively. It has no effect on other fungi, yeast and bacteria. |
||
BBF-01264 |
Glucopiericidin B (108073-61-6) Inquiry |
|
It is produced by the strain of Streptomyces pactum S48727. Its antibacterial activity was stronger than Piericidin A1, and its inhibitory effect on antibody formation was also stronger than Piericidin A1. |
||
BBF-01288 |
Griseolutein A (573-84-2) Inquiry |
|
It is produced by the strain of Streptomyces griseoluteus. Griseolutein A and Griseolutein B have similar activitiy against gram-positive and negative bacteria. |
||
BBF-01289 |
Griseolutein B (2072-68-6) Inquiry |
|
It is produced by the strain of Streptomyces griseoluteus. Griseolutein A and Griseolutein B have similar activitiy against gram-positive and negative bacteria, and Griseolutein B also inhibits rickettsia, trichomonas vaginalis and Ehrlichite ascites cancer. |
||
BBF-01341 | ||
It is produced by the strain of Pseudomonas. It has activity against Candida albicans, Staphylococcus aureus, Vibrio anguillarum and V. Harveyi. |
||
BBF-01372 |
Detoxin C1 (74717-53-6) Inquiry |
|
It is produced by the strain of Streptomyces caespitosus var. detoxicus 7072 GCl and Str. mobaraensis. |
||
BBF-01373 |
Detoxin D1 (37878-19-6) Inquiry |
|
It is produced by the strain of Streptomyces caespitosus var. detoxicus 7072 GCl and Str. mobaraensis. |
||
BBF-01395 |
Difficidin (95152-88-8) Inquiry |
|
Difficidin is produced by the strain of Bacillus subtilis. It has broad spectrum of aerobic and anaerobic bacterial activity. |
||
BBF-01399 | ||
It is produced by the strain of Chrysosporium sp. FO-4712 and it can be used as a herbicide. |
||
BBF-01402 | ||
Produced by the strain of Streptomyces thermoviolaceus subsp. pigenes var. WR-141. It is a red pigment with activity against Bacillus cereus. |
||
BBF-01403 | ||
It is produced by the strain of Hypomyces trichothecoides. Dihydrohypothemycin has anti-tsutsugamushi activity. |
||
BBF-01404 | ||
Dihydromaitophilin has the ability of anti-plasmopara viticola. |
||
BBF-01407 | ||
Dihydroepiepoformin is produced by the strain of Penicillum patulum. It inhibited IL-1 activity with IC50 of 100 μg/mL. |
||
BBF-01410 | ||
Dihydropergillin is produced by the strain of Aspergillus ustus. It can inhibit the growth of plants. |
||
BBF-01411 |
5,10-dihydrophencomycin methyl ester (193421-85-1) Inquiry |
|
It has very weak activity against Escherichia coli and Bacillus subtilis. |
||
BBF-01412 |
L-2,5-Dihydrophenylalanine (16055-12-2) Inquiry |
|
It is produced by the strain of Streptomyces sp. L-2,5-Dihydrophenylalanine can cause apoptosis of HL-60 in human myeloblastoid leukemia cells. |
||
BBF-01457 |
Actofunicone (358376-44-0) Inquiry |
|
It is produced by the strain of Talararomyces flavus FKI-0076. Actofunicone is an antifungal activity enhancer of Miconazole. |